ProShares Equities For Rising Rates ETF (NASDAQ:EQRR – Get Free Report)’s share price were down 2.4% during trading on Monday. The company traded as low as $82.72 and last traded at $82.8040. Approximately 6,921 shares traded hands during trading, a decline of 58% from the average session volume of 16,577 shares. The stock had previously closed at $84.85.
ProShares Equities For Rising Rates ETF Price Performance
The business’s 50 day moving average price is $86.19 and its 200-day moving average price is $77.89. The firm has a market capitalization of $39.75 million, a price-to-earnings ratio of 16.51 and a beta of 0.94.
Hedge Funds Weigh In On ProShares Equities For Rising Rates ETF
Institutional investors and hedge funds have recently made changes to their positions in the stock. Citadel Advisors LLC acquired a new position in shares of ProShares Equities For Rising Rates ETF during the 2nd quarter worth $1,373,000. Independent Financial Group LLC acquired a new stake in ProShares Equities For Rising Rates ETF in the 1st quarter valued at about $531,000. Envestnet Asset Management Inc. purchased a new position in ProShares Equities For Rising Rates ETF during the 2nd quarter valued at about $520,000. Geneos Wealth Management Inc. purchased a new position in ProShares Equities For Rising Rates ETF during the 1st quarter valued at about $25,000. Finally, Money Concepts Capital Corp acquired a new position in ProShares Equities For Rising Rates ETF during the first quarter worth about $292,000.
About ProShares Equities For Rising Rates ETF
The ProShares Equities for Rising Rates ETF (EQRR) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of 50 US-listed large-cap stocks that are anticipated to perform favorably during periods of rising interest rates. EQRR was launched on Jul 24, 2017 and is managed by ProShares.
Read More
- Five stocks we like better than ProShares Equities For Rising Rates ETF
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for ProShares Equities For Rising Rates ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Equities For Rising Rates ETF and related companies with MarketBeat.com's FREE daily email newsletter.
